Jonathan S. Wolin is Chief of Staff, CCO & GC of Jaguar Health, Inc.. Currently has a direct ownership of 2,012 shares of JAGX, which is worth approximately $2,233. The most recent transaction as insider was on May 17, 2024, when has been sold 871 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.01K
0% 3M change
98.98% 12M change
Total Value Held $2,233

Jonathan S. Wolin Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 17 2024
BUY
Exercise of conversion of derivative security
-
871 Added 30.21%
2,012 Common Stock
Apr 05 2024
BUY
Exercise of conversion of derivative security
-
89 Added 7.24%
1,141 Common Stock
Aug 14 2023
BUY
Grant, award, or other acquisition
-
196,628 Added 49.87%
197,680 Common Stock
May 17 2023
BUY
Exercise of conversion of derivative security
-
871 Added 45.29%
1,052 Common Stock
Apr 05 2023
BUY
Exercise of conversion of derivative security
-
88 Added 32.71%
181 Common Stock
Dec 31 2022
BUY
Open market or private purchase
$9 $0.03 p/Share
317 Added 4.34%
6,983 Common Stock
Apr 05 2022
BUY
Exercise of conversion of derivative security
-
6,666 Added 50.0%
6,666 Common Stock
JSW

Jonathan S. Wolin

Chief of Staff, CCO & GC
San Francisco, CA

Track Institutional and Insider Activities on JAGX

Follow Jaguar Health, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JAGX shares.

Notify only if

Insider Trading

Get notified when an Jaguar Health, Inc. insider buys or sells JAGX shares.

Notify only if

News

Receive news related to Jaguar Health, Inc.

Track Activities on JAGX